(LYB) LyondellBasell Industries - Ratings and Ratios
Olefins, Polyolefins, Polypropylene, Polyethylene, Catalysts
Description: LYB LyondellBasell Industries October 30, 2025
LyondellBasell Industries N.V. (NYSE: LYB) is a vertically integrated chemical producer operating across six business segments-Olefins & Polyolefins (Americas, Europe/Asia/International), Intermediates & Derivatives, Advanced Polymer Solutions, Refining, and Technology. The company manufactures core petrochemical building blocks (e.g., ethylene, propylene, butadiene, aromatics) and downstream products such as polyethylene, polypropylene homopolymers & copolymers, propylene oxide, and specialty polymers (catalloy, poly-butene-1). It also refines heavy, high-sulfur crude into gasoline and distillates and licenses polyolefin process technologies and catalysts.
Key operational metrics from FY 2024 show LYB’s adjusted EBITDA of $5.2 bn and a segment-level EBITDA margin of ~13 % in Olefins & Polyolefins, reflecting strong demand for packaging-grade resins. Capacity utilization in its ethylene crackers averaged 92 % during Q3 2024, indicating limited upside from incremental feedstock cost recovery. The company’s earnings are highly sensitive to ethylene and propylene price spreads, which are driven by global natural-gas feedstock costs and macro-level demand for construction and automotive plastics.
Sector-wide, the commodity chemicals market is being reshaped by three forces: (1) volatile natural-gas prices that set feedstock costs, (2) a sustained shift toward higher-value, recycled-content polymers in Europe and North America, and (3) tightening emissions regulations that favor integrated players capable of deploying low-carbon technologies-areas where LYB has announced several decarbonization projects.
For a deeper quantitative assessment of LYB’s valuation metrics, the ValueRay platform offers a granular, data-driven dashboard you may find useful.
LYB Stock Overview
| Market Cap in USD | 14,539m |
| Sub-Industry | Commodity Chemicals |
| IPO / Inception | 2010-04-28 |
LYB Stock Ratings
| Growth Rating | -65.1% |
| Fundamental | 38.1% |
| Dividend Rating | 77.9% |
| Return 12m vs S&P 500 | -53.1% |
| Analyst Rating | 3.27 of 5 |
LYB Dividends
| Dividend Yield 12m | 12.60% |
| Yield on Cost 5y | 9.44% |
| Annual Growth 5y | 5.84% |
| Payout Consistency | 88.1% |
| Payout Ratio | 3.2% |
LYB Growth Ratios
| Growth Correlation 3m | -85.1% |
| Growth Correlation 12m | -87.7% |
| Growth Correlation 5y | -2.7% |
| CAGR 5y | -16.61% |
| CAGR/Max DD 3y (Calmar Ratio) | -0.30 |
| CAGR/Mean DD 3y (Pain Ratio) | -1.04 |
| Sharpe Ratio 12m | -1.84 |
| Alpha | -61.58 |
| Beta | 0.890 |
| Volatility | 38.14% |
| Current Volume | 5281.3k |
| Average Volume 20d | 4951.1k |
| Stop Loss | 40.9 (-4.9%) |
| Signal | -0.48 |
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income (-309.0m TTM) > 0 and > 6% of Revenue (6% = 1.49b TTM) |
| FCFTA 3.48m (>2.0%) and ΔFCFTA 348.2mpp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -27.59% (prev 17.26%; Δ -44.85pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 4.29m (>3.0%) and CFO 2.67b > Net Income -309.0m (YES >=105%, WARN >=100%) |
| Net Debt (13.08b) to EBITDA (835.0m) ratio: 15.66 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.00 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (326.0) change vs 12m ago -100.00% (target <= -2.0% for YES) |
| Gross Margin -19.02% (prev 12.13%; Δ -31.15pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 133.3% (prev 105.0%; Δ 28.31pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -0.54 (EBITDA TTM 835.0m / Interest Expense TTM 386.0m) >= 6 (WARN >= 3) |
ValueRay F-Score (Strict, 0-100) 38.12
| 1. Piotroski 5.0pt = 0.0 |
| 2. FCF Yield 7.84% = 3.92 |
| 3. FCF Margin 8.72% = 2.18 |
| 4. Debt/Equity 1.23 = 1.79 |
| 5. Debt/Ebitda 15.66 = -2.50 |
| 6. ROIC - WACC (= -6.32)% = -7.90 |
| 7. RoE -2.62% = -0.44 |
| 8. Rev. Trend -67.53% = -5.06 |
| 9. EPS Trend -77.37% = -3.87 |
What is the price of LYB shares?
Over the past week, the price has changed by -7.32%, over one month by -12.44%, over three months by -12.20% and over the past year by -46.54%.
Is LyondellBasell Industries a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of LYB is around 41.57 USD . This means that LYB is currently overvalued and has a potential downside of -3.37%.
Is LYB a buy, sell or hold?
- Strong Buy: 5
- Buy: 1
- Hold: 13
- Sell: 1
- Strong Sell: 2
What are the forecasts/targets for the LYB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 57 | 32.5% |
| Analysts Target Price | 57 | 32.5% |
| ValueRay Target Price | 45.1 | 4.8% |
LYB Fundamental Data Overview November 01, 2025
P/E Trailing = 96.1702
P/E Forward = 12.987
P/S = 0.3761
P/B = 1.3323
P/EG = 0.8541
Beta = 0.89
Revenue TTM = 24.83b USD
EBIT TTM = -209.0m USD
EBITDA TTM = 835.0m USD
Long Term Debt = 10.53b USD (from longTermDebt, last fiscal year)
Short Term Debt = 1.08b USD (from shortTermDebt, last quarter)
Debt = 13.08b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 13.08b USD (from netDebt column, last quarter)
Enterprise Value = 27.62b USD (14.54b + Debt 13.08b - CCE 983.0)
Interest Coverage Ratio = -0.54 (Ebit TTM -209.0m / Interest Expense TTM 386.0m)
FCF Yield = 7.84% (FCF TTM 2.17b / Enterprise Value 27.62b)
FCF Margin = 8.72% (FCF TTM 2.17b / Revenue TTM 24.83b)
Net Margin = -1.24% (Net Income TTM -309.0m / Revenue TTM 24.83b)
Gross Margin = -19.02% ((Revenue TTM 24.83b - Cost of Revenue TTM 29.55b) / Revenue TTM)
Gross Margin QoQ = none% (prev 10.45%)
Tobins Q-Ratio = 44.4m (set to none) (Enterprise Value 27.62b / Total Assets 622.0)
Interest Expense / Debt = 1.25% (Interest Expense 163.0m / Debt 13.08b)
Taxrate = 3.18% (-27.0m / -848.0m)
NOPAT = -202.3m (EBIT -209.0m * (1 - 3.18%)) [loss with tax shield]
Current Ratio = 0.00 (Total Current Assets 622.0 / Total Current Liabilities 6.85b)
Debt / Equity = 1.23 (Debt 13.08b / totalStockholderEquity, last quarter 10.60b)
Debt / EBITDA = 15.66 (Net Debt 13.08b / EBITDA 835.0m)
Debt / FCF = 6.04 (Net Debt 13.08b / FCF TTM 2.17b)
Total Stockholder Equity = 11.79b (last 4 quarters mean from totalStockholderEquity)
RoA = -49.7m% (out of range, set to none)
RoE = -2.62% (Net Income TTM -309.0m / Total Stockholder Equity 11.79b)
RoCE = -0.94% (EBIT -209.0m / Capital Employed (Equity 11.79b + L.T.Debt 10.53b))
RoIC = -0.86% (negative operating profit) (NOPAT -202.3m / Invested Capital 23.59b)
WACC = 5.46% (E(14.54b)/V(27.62b) * Re(9.29%) + D(13.08b)/V(27.62b) * Rd(1.25%) * (1-Tc(0.03)))
Discount Rate = 9.29% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -81.65 | Cagr: -99.90%
[DCF Debug] Terminal Value 65.38% ; FCFE base≈1.94b ; Y1≈1.29b ; Y5≈606.1m
Fair Price DCF = 30.27 (DCF Value 9.74b / Shares Outstanding 321.6m; 5y FCF grow -38.98% → 3.0% )
EPS Correlation: -77.37 | EPS CAGR: -56.45% | SUE: -4.0 | # QB: 0
Revenue Correlation: -67.53 | Revenue CAGR: -10.85% | SUE: 0.25 | # QB: 0
Additional Sources for LYB Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle